(1)
Immunosuppression Management in Renal Transplant Recipients With Normal-Immunological Risk: 10-Year Results from the Swiss Transplant Cohort Study. Swiss Med Wkly 2020, 150 (4950), w20354. https://doi.org/10.4414/smw.2020.20354.